⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12807817 | 1.00 | — | — | |
| SCHEMBL1861994 | 0.85 | — | — | |
| SCHEMBL24668805 | 0.81 | — | — | |
| SCHEMBL24668379 | 0.81 | — | — | |
| SCHEMBL17664726 | 0.79 | KDM4E (0.48) | — | |
| SCHEMBL13696409 | 0.79 | — | — | |
| SCHEMBL14970377 | 0.78 | — | — | |
| SCHEMBL48989 | 0.78 | — | — | |
| SCHEMBL17764072 | 0.78 | — | — | |
| SCHEMBL5669163 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346913-A1 | NOVEL METHODS FOR IDENTIFICATION AND USE OF UPSTREAM OPEN READING FRAMES | GENXTRAITS INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-11479783-B2 | Transgenic plants with enhanced agronomic traits | MONSANTO TECHNOLOGY LLC (US) | 2022-10-25 | — | — | US | disclosed |
| US-10869846-B2 | N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress | SENTIENT LIFESCIENCES, INC. (US) | 2020-12-22 | — | — | US | disclosed |
| US-20190111009-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | SENTIENT LIFESCIENCES, INC. | 2019-04-18 | — | — | US | disclosed |
| US-20170135970-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | GOLDSTEIN GLENN A (US) | 2017-05-18 | — | — | US | disclosed |
| US-20170135970-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | GOLDSTEIN GLENN A (US) | 2017-05-18 | — | — | US | disclosed |
| US-20160206576-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | GOLDSTEIN GLENN A (US) | 2016-07-21 | — | — | US | disclosed |
| US-20160206576-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | GOLDSTEIN GLENN A (US) | 2016-07-21 | — | — | US | disclosed |
| US-9216162-B2 | N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress | GOLDSTEIN GLENN A (US) | 2015-12-22 | — | — | US | disclosed |
| US-9216162-B2 | N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress | GOLDSTEIN GLENN A (US) | 2015-12-22 | — | — | US | disclosed |
| US-8354449-B2 | N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress | SENTIENT LIFESCIENCES, INC. | 2013-01-15 | — | — | US | disclosed |
| US-20120151635-A1 | METHODS OF AFFECTING NITROGEN ASSIMILATION IN PLANTS | NEW YORK UNIVERSITY | 2012-06-14 | — | — | US | disclosed |
| US-20110265221-A1 | Transgenic plants with enhanced agronomic traits | MONSANTO TECHNOLOGY LLC (US) | 2011-10-27 | — | — | US | disclosed |
| WO-2011044230-A2 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS | GOLDSTEIN GLENN A (US) | 2011-04-14 | — | — | WO | disclosed |
| US-20100137441-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | SENTIENT LIFESCIENCES, INC. | 2010-06-03 | — | — | US | disclosed |
| US-20100137441-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | SENTIENT LIFESCIENCES, INC. | 2010-06-03 | — | — | US | disclosed |
| US-20100120920-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | SENTIENT LIFESCIENCES, INC. | 2010-05-13 | — | — | US | disclosed |
| US-20100120920-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | SENTIENT LIFESCIENCES, INC. | 2010-05-13 | — | — | US | disclosed |
| US-20090234011-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | DAVID PHARMACEUTICALS | 2009-09-17 | — | — | US | disclosed |
| US-20090234011-A1 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS | DAVID PHARMACEUTICALS | 2009-09-17 | — | — | US | disclosed |